Differential combination of cytokine and interferon- γ +874 T/A polymorphisms determines disease severity in pulmonary tuberculosis

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Ansari, Ambreen ^a   Hasan, Zahra ^a   Dawood, Ghaffar ^b   Hussain, Rabia ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b Masoomeen General Hospital   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; THREONINE; GAMMA INTERFERON; IL10 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; INTERLEUKIN 10; INTERLEUKIN 6;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ETHNIC DIFFERENCE; FEMALE; GENE; GENE DOSAGE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; INTERFERON GAMMA GENE; INTERLEUKIN 10 GENE; INTERLEUKIN 6 GENE; LUNG PARENCHYMA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR NECROSIS FACTOR ALPHA GENE; DEMOGRAPHY; DONOR; GENETIC PREDISPOSITION; GENETICS; HOSPITALIZATION; IMMUNOLOGY; PAKISTAN;

ADULT; DEMOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-6; MALE; PAKISTAN; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX; TISSUE DONORS; TUBERCULOSIS, PULMONARY;

EID: 82255173844     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027848     Document Type: Article

References (48)

1. WHO (2009) Global tuberculosis control- epidemiology, strategy, financing. WHO Report 2009.
2. WHO, UNICEF (2009) Review of National Immunization coverage, Pakistan. 1-10.
3. Kaufmann SH, Cole S, Mizrahi V, Rubin E, Nathan C, (2005) Mycobacterium tuberculosis and the host response. J Exp Med 201: 1693-1697.
4. Comstock G, (1982) Epidemiology of Tuberculosis. Am J Respir Dis 125: 8-15.
5. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, et al. (1993) An Essential role for Interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 178: 2249-2254.
6. Jouanguy E, Dupuis S, Pallier A, Doffinger R, Fondaneche M-D, et al. (2000) In a novel form of INF-g receptor 1 deficiency, cell surface receptors fail to bind IFN-g. J Clin Invest 105: 1429-1436.
7. Pacheco AG, Cardoso CC, Moraes MO, (2008) IFNG +874T/A, IL10 -1082G/A and TNF -308G/A polymorphisms in association with tuberculosis susceptibility: a meta-analysis study. Hum Genet 123: 477-484.
8. Rossouw M, Nel HJ, Cooke GS, van Helden PD, Hoal EG, (2003) Association between tuberculosis and a polymorphic NFkappaB binding site in the interferon gamma gene. Lancet 361: 1871-1872.
9. Leandro AC, Rocha MA, Cardoso CS, Bonecini-Almeida MG, (2009) Genetic polymorphisms in vitamin D receptor, vitamin D-binding protein, Toll-like receptor 2, nitric oxide synthase 2, and interferon-gamma genes and its association with susceptibility to tuberculosis. Braz J Med Biol Res 42: 312-322.
10. Mansouri D, Adimi P, Mirsaeidi M, Mansouri N, Khalilzadeh S, et al. (2005) Inherited disorders of the IL-12-IFN-gamma axis in patients with disseminated BCG infection. Eur J Pediatr 164: 753-757.
11. Chapgier A, Boisson-Dupuis S, Jouanguy E, Vogt G, Feinberg J, et al. (2006) Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease 4. PLoS Genet 2: e131.
12. Cooke GS, Campbell SJ, Sillah J, Gustafson P, Bah B, et al. (2006) Polymorphism within the Interferon-g/Receptor Complex is associated with Pulmonary Tuberculosis. Am J Respir Crit Care Med 174: 339-343.
13. Keane J, (2005) TNF-blocking agent and tuberculosis: new drugs illuminate an old topic. Rheumatology 44: 714-720.
14. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D, (1994) Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 371: 508-510.
15. Cabrera M, Shaw MA, Sharples C, Williams H, Castes M, et al. (1995) Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 182: 1259-1264.
16. Santos AR, Almeida AS, Suffys PN, Moraes MO, Filho VF, et al. (2000) Tumor necrosis factor promoter polymorphism (TNF2) seems to protect against development of severe forms of leprosy in a pilot study in Brazilian patients. Int J Lepr Other Mycobact Dis 68: 325-327.
17. Delgado JC, Baena A, Thim S, Goldfeld AE, (2002) Ethnic-specific genetic associations with pulmonary tuberculosis. J Infect Dis 186: 1463-1468.
18. Fitness J, Floyd S, Warndorff DK, Sichali L, Malema S, et al. (2004) Large-scale candidate gene study of tuberculosis susceptibility in the Karonga district of northern Malawi. Am J Trop Med Hyg 71: 341-349.
19. Kumar V, Khosla R, Gupta V, Sarin BC, Sehajpal PK, (2008) Differential association of tumour necrosis factor-alpha single nucleotide polymorphism (-308) with tuberculosis and bronchial asthma. Natl Med J India 21: 120-122.
20. Henao MI, Montes C, Paris SC, Garcia LF, (2006) Cytokine gene polymorphisms in Colombian patients with different clinical presentations of tuberculosis. Tuberculosis (Edinb) 86: 11-19.
21. Bogdan C, Vodovotz Y, Nathan C, (1991) Macrophages Deactivation by interleukin 10. J Exp Med 174: 1549-1555.
22. O'Garra A, Vieira PL, Vieira P, Goldfeld AE, (2004) IL-10 producing and naturally occurring CD4+ Tregs: limiting collateral damage. J Clin Invest 114: 1372-1378.
23. Lopez-Maderuelo D, Arnalich F, Serantes R, Gonzalez A, Codoceo R, et al. (2003) Interferon-gamma and interleukin-10 gene polymorphisms in pulmonary tuberculosis. Am J Respir Crit Care Med 167: 970-975.
24. Howard M, O'Garra A, (1992) Biological properties of interleukin 10. Immunol Today 13: 198-200.
25. Zhang J, Chen Y, Nie XB, Wu WH, Zhang H, et al. (2011) Interleukin-10 polymorphisms and tuberculosis susceptibility: a meta-analysis. Int J Tuberc Lung Dis 15: 594-601.
26. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, et al. (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102: 1369-1376.
27. Selvaraj P, Alagarasu K, Harishankar M, Vidyarani M, Nisha RD, et al. (2008) Cytokine gene polymorphisms and cytokine levels in pulmonary tuberculosis. Cytokine 43: 26-33.
28. Doganci A, Eigenbrod T, Krug N, De Sanctis GT, Hausding M, et al. (2005) The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo. J Clin Invest 115: 313-325.
29. Hussain R, Talat N, Ansari A, Shahid F, Hasan Z, et al. (2011) Endogenously Activated Interleukin-4 Differentiates Disease Progressors and Non-Progressors in Tuberculosis Susceptible Families: A 2-Year Biomarkers Follow-Up Study. J Clin ImmunolDOI 10.1007/s10875-011-9566-y.
30. Velez DR, Hulme WF, Myers JL, Weinberg JB, Levesque MC, et al. (2009) NOS2A, TLR4, and IFNGR1 interactions influence pulmonary tuberculosis susceptibility in African-Americans. Hum Genet 126: 643-653.
31. Moller M, Nebel A, van Helden PD, Schreiber S, Hoal EG, (2010) Analysis of eight genes modulating interferon gamma and human genetic susceptibility to tuberculosis: a case-control association study. BMC Infect Dis 10: 154.
32. Crofton J, (1990) Crofton and Douglas Respiratory Diseases. Clinical features of tuberculosis London Blackwell Scientific pp. 395-421.
33. Maher D, Chaulet P, Spinaci S, Harries A, (1997) Treatment of Tuberculosis- Guidelines for National Programmes. World Health Organization pp. 1-78.
34. Hussain R, Talat N, Shahid F, Dawood G, (2009) Biomarker changes associated with Tuberculin Skin Test (TST) conversion: a two-year longitudinal follow-up study in exposed household contacts. PLoS ONE 4: e7444.
35. Bagheri M, Abdi-Rad I, Omrani D, Khalkhali HR, (2006) Heterogeneity of cytokine single-nucleotide polymorphsims among the Iranian and in the other East-South Asian populations. Transfusion Medicine 16: 192-199.
36. Akhtar S, White F, Hasan R, Rozi S, Younus M, et al. (2007) Hyperendemic pulmonary tuberculosis in peri-urban areas of Karachi, Pakistan. BMC Public Health 7: 70.
37. Ansari A, Talat N, Jamil B, Hasan Z, Razzaki T, et al. (2009) Cytokine gene polymorphisms across tuberculosis clinical spectrum in Pakistani patients. PLoS ONE 4: e4778.
38. Casanova JL, Abel L, (2007) Human genetics of infectious diseases: a unified theory. EMBO J 26: 915-922.
39. Kindler V, Sappino AP, Grau GE, Piguet PF, Via LE, et al. (1989) The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56: 731-740.
40. Bellamy R, (2003) Susceptibility to mycobacterial infections: the importance of host genetics. Genes Immun 4: 4-11.
41. Lio D, Marino V, Serauto A, Gioia V, Scola L, et al. (2002) Genotype frequencies of the +874T→A single nucleotide polymorphism in the first intron of the interferon-gamma gene in a sample of Sicilian patients affected by tuberculosis. Eur J Immunogenet 29: 371-374.
42. Etokebe GE, Bulat-Kardum L, Johansen MS, Knezevic J, Balen S, et al. (2006) Interferon-gamma gene (T874A and G2109A) polymorphisms are associated with microscopy-positive tuberculosis. Scand J Immunol 63: 136-141.
43. Sallakci N, Coskun M, Berber Z, Gürkan F, Kocamaz H, et al. (2007) Interferon-gamma gene+874T-A polymorphism is associated with tuberculosis and gamma interferon response. Tuberculosis 87: 225-230.
44. Vallinoto AC, Graca ES, Araujo MS, Azevedo VN, Cayres-Vallinoto I, et al. (2010) IFNG +874T/A polymorphism and cytokine plasma levels are associated with susceptibility to Mycobacterium tuberculosis infection and clinical manifestation of tuberculosis. Hum Immunol 71: 692-696.
45. Hashemi M, Sharifi-Mood B, Nezamdoost M, Moazeni-Roodi A, Naderi M, et al. (2011) Functional polymorphism of interferon-gamma (IFN-gamma) gene +874T/A polymorphism is associated with pulmonary tuberculosis in Zahedan, Southeast Iran. Prague Med Rep 112: 38-43.
46. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, et al. (1993) Disseminated tuberculosis in Interferon gamma gene disrupted Mice. J Exp Med 178: 2243-2247.
47. Dupuis S, Doffinger R, Picard C, Fieschi C, Altare F, et al. (2000) Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion. Immunol Rev 178: 129-137.
48. Jamil B, Shahid F, Hasan Z, Nasir N, Razzaki T, et al. (2007) Interferongamma/IL10 ratio defines the disease severity in pulmonary and extra pulmonary tuberculosis. Tuberculosis (Edinb) 87: 279-287.